Literature DB >> 28837721

Visual Function in Asymptomatic Patients With Homozygous Sickle Cell Disease and Temporal Macular Atrophy.

Gilles C Martin1, Charlotte Dénier1, Olivia Zambrowski1,2, David Grévent3, Lenaïc Bruère1, Valentine Brousse4, Mariane de Montalembert4, Dominique Brémond-Gignac1,5, Matthieu P Robert1,6.   

Abstract

Importance: Temporal macular involvement in sickle cell disease can now easily be detected by optical coherence tomography (OCT). However, while recent studies have demonstrated its high prevalence, little is known about its potential consequences on visual function. Objective: To assess the visual function of patients with sickle cell disease with no visual symptoms despite temporal macular atrophy. Design, Setting, and Participants: This retrospective case series included data collection and explorations made in a single referral center for sickle cell disease in 2016. Three patients with sickle cell disease exhibiting preserved visual acuity but showing temporal macular retinal atrophy were included. Exposures: Patients underwent the following explorations: best-corrected distance and near visual acuity evaluation; dilated fundus examination; OCT with 12 × 6-mm thickness map; horizontal, vertical, and en face sections; OCT angiography of the 6 × 6-mm perifoveal retina; 30° and 12° central visual fields; Lanthony 15-hue color vision test; automated static contrast sensitivity test; and global electroretinography. Main Outcomes and Measures: The OCT thickness maps were checked for areas of retinal thinning, appearing as blue patches. When present, these areas were compared with the areas of superficial and deep capillary flow loss on OCT angiography and with the scotomas on visual fields. Contrast sensitivity and color vision loss were quantified.
Results: All 3 patients included had homozygous sickle cell disease. They presented with a 20/20 distance visual acuity, and Parinaud 1,5 near visual acuity in both eyes. They were all followed up for a severe cerebral vasculopathy related to sickle cell disease. The areas of atrophy involved the inner retinal layers and were associated with an absence of signal in the deep capillary plexuses in OCT angiography. These patches of retinal thinning were also matching with scotomas in the automated visual fields. Color vision ability and contrast sensitivity were impaired in all patients. Global electroretinography findings were normal. Conclusions and Relevance: Temporal macular atrophy in sickle cell disease may have direct consequences on visual function, including in children, even when visual acuity is preserved. Optical coherence tomographic imaging may be warranted when evaluating patients with sickle cell disease, even if asymptomatic with 20/20 visual acuity.

Entities:  

Mesh:

Year:  2017        PMID: 28837721      PMCID: PMC5847113          DOI: 10.1001/jamaophthalmol.2017.3008

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  15 in total

1.  Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation.

Authors:  F Bernaudin; S Verlhac; F Fréard; F Roudot-Thoraval; M Benkerrou; I Thuret; R Mardini; J P Vannier; E Ploix; M Romero; C Cassé-Perrot; M Helly; E Gillard; G Sebag; H Kchouk; J P Pracros; B Finck; J N Dacher; V Ickowicz; C Raybaud; M Poncet; E Lesprit; P H Reinert; P Brugières
Journal:  J Child Neurol       Date:  2000-05       Impact factor: 1.987

Review 2.  Sickle cell disease and the eye: old and new concepts.

Authors:  Mohammed Elagouz; Sreedhar Jyothi; Bhaskar Gupta; Sobha Sivaprasad
Journal:  Surv Ophthalmol       Date:  2010-05-10       Impact factor: 6.048

3.  Temporal macular thinning on spectral-domain optical coherence tomography in proliferative sickle cell retinopathy.

Authors:  Ravi K Murthy; Sandeep Grover; Kakarla V Chalam
Journal:  Arch Ophthalmol       Date:  2011-02

4.  Macular and perimacular vascular remodelling sickling haemoglobinopathies.

Authors:  G K Asdourian; K C Nagpal; B Busse; M Goldbaum; D Patriankos; M F Rabb; M F Goldberg
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

5.  ISCEV Standard for full-field clinical electroretinography (2015 update).

Authors:  Daphne L McCulloch; Michael F Marmor; Mitchell G Brigell; Ruth Hamilton; Graham E Holder; Radouil Tzekov; Michael Bach
Journal:  Doc Ophthalmol       Date:  2014-12-14       Impact factor: 2.379

6.  Asymptomatic atrophy of the temporal median raphe of the retina associated with cerebral vasculopathy in homozygous sickle cell disease.

Authors:  Matthieu P Robert; Isabelle Ingster-Moati; Olivier Roche; Nathalie Boddaert; Mariane de Montalembert; Valentine Brousse; Manoelle Kossorotoff; Jean-Louis Dufier; Céline Faure
Journal:  J AAPOS       Date:  2012-08       Impact factor: 1.220

7.  Sickling hemoglobinopathies; macular and perimacular vascular abnormalities.

Authors:  T S Stevens; B Busse; C B Lee; M B Woolf; S O Galinos; M F Goldberg
Journal:  Arch Ophthalmol       Date:  1974-12

8.  CORRELATION OF MULTIMODAL IMAGING IN SICKLE CELL RETINOPATHY.

Authors:  Khalil Ghasemi Falavarjani; Adrienne W Scott; Kang Wang; Ian C Han; Xuejing Chen; Michael Klufas; Jean-Pierre Hubschman; Steven D Schwartz; Srinivas R Sadda; David Sarraf; Irena Tsui
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

Review 9.  Vasoocclusive diseases of the posterior pole.

Authors:  L M Jampol; M F Rabb
Journal:  Int Ophthalmol Clin       Date:  1981

10.  Macular Microangiopathy in Sickle Cell Disease Using Optical Coherence Tomography Angiography.

Authors:  Wilfried Minvielle; Violaine Caillaux; Salomon Y Cohen; François Chasset; Olivia Zambrowski; Alexandra Miere; Eric H Souied
Journal:  Am J Ophthalmol       Date:  2015-12-31       Impact factor: 5.258

View more
  5 in total

1.  Quantification of intermittent retinal capillary perfusion in sickle cell disease.

Authors:  Davis B Zhou; Maria V Castanos; Alexander Pinhas; Peter Gillette; Justin V Migacz; Richard B Rosen; Jeffrey Glassberg; Toco Y P Chui
Journal:  Biomed Opt Express       Date:  2021-04-21       Impact factor: 3.732

Review 2.  Artificial intelligence for improving sickle cell retinopathy diagnosis and management.

Authors:  Sophie Cai; Ian C Han; Adrienne W Scott
Journal:  Eye (Lond)       Date:  2021-05-06       Impact factor: 4.456

3.  Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula.

Authors:  Laura Dell'Arti; Giulio Barteselli; Lorenzo Riva; Elisa Carini; Giovanna Graziadei; Eleonora Benatti; Alessandro Invernizzi; Maria D Cappellini; Francesco Viola
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

4.  Retinopathy in Egyptian patients with sickle cell disease: A cross-sectional study.

Authors:  Tamer Hassan; Mohamed Badr; Diana Hanna; Mohamed Arafa; Ahmed Elhewala; Sherief Dabour; Saad Shehata; Doaa Abdel Rahman
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

Review 5.  [Maculopathy in sickle cell disease].

Authors:  Isabel Bachmeier; Christiane Blecha; Jürgen Föll; Daniel Wolff; Herbert Jägle
Journal:  Ophthalmologe       Date:  2021-01-27       Impact factor: 1.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.